Astellas Pharma Inc.

OTCPK:ALPM.Y Stock Report

Market Cap: US$18.3b

Astellas Pharma Future Growth

Future criteria checks 3/6

Astellas Pharma is forecast to grow earnings and revenue by 25.6% and 0.6% per annum respectively. EPS is expected to grow by 26% per annum. Return on equity is forecast to be 11.9% in 3 years.

Key information

25.6%

Earnings growth rate

26.0%

EPS growth rate

Pharmaceuticals earnings growth23.9%
Revenue growth rate0.6%
Future return on equity11.9%
Analyst coverage

Good

Last updated25 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:ALPM.Y - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20271,972,110217,037305,069385,62415
3/31/20261,853,429143,323309,061339,33516
3/31/20251,781,94585,590246,600340,34116
9/30/20241,772,15554,746125,654200,804N/A
6/30/20241,701,80621,51992,795172,877N/A
3/31/20241,603,67217,045100,981172,475N/A
12/31/20231,543,3244,198136,404216,089N/A
9/30/20231,523,57238,090151,562236,992N/A
6/30/20231,511,818107,031205,852291,133N/A
3/31/20231,518,61998,714239,438327,767N/A
12/31/20221,468,235136,430183,399260,759N/A
9/30/20221,406,682148,911214,107257,916N/A
6/30/20221,351,811118,211215,849266,193N/A
3/31/20221,296,163124,086205,277257,444N/A
12/31/20211,300,914120,167236,959290,559N/A
9/30/20211,285,714119,360248,993331,268N/A
6/30/20211,268,702100,863261,235325,326N/A
3/31/20211,249,528120,589229,402306,843N/A
12/31/20201,253,215138,307196,679276,851N/A
9/30/20201,265,853139,722146,751235,299N/A
6/30/20201,273,678187,306135,534236,186N/A
3/31/20201,300,843195,411144,110221,998N/A
12/31/20191,289,855220,751151,021225,239N/A
9/30/20191,309,722246,925182,693248,203N/A
6/30/20191,311,397226,224176,251228,863N/A
3/31/20191,306,348222,265206,502258,630N/A
12/31/20181,305,901213,600254,876300,955N/A
9/30/20181,307,658186,429265,976309,442N/A
6/30/20181,306,830176,770N/A290,301N/A
3/31/20181,300,316164,679N/A312,614N/A
12/31/20171,305,521182,515N/A264,549N/A
9/30/20171,299,746185,754N/A260,795N/A
6/30/20171,296,484194,556N/A276,954N/A
3/31/20171,311,665218,701N/A235,612N/A
12/31/20161,312,627207,940N/A325,459N/A
9/30/20161,336,878205,818N/A308,800N/A
6/30/20161,366,799215,678N/A302,245N/A
3/31/20161,372,706193,687N/A313,737N/A
12/31/20151,360,153185,659N/A207,806N/A
9/30/20151,340,307168,805N/A182,815N/A
6/30/20151,295,761144,617N/A156,675N/A
3/31/20151,247,259135,856N/A187,686N/A
12/31/20141,205,276124,154N/AN/AN/A
9/30/20141,177,660112,663N/A224,809N/A
6/30/20141,159,218104,614N/AN/AN/A
3/31/20141,139,90990,874N/A214,257N/A
12/31/20131,137,82479,679N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALPM.Y's forecast earnings growth (25.6% per year) is above the savings rate (2.6%).

Earnings vs Market: ALPM.Y's earnings (25.6% per year) are forecast to grow faster than the US market (15.4% per year).

High Growth Earnings: ALPM.Y's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ALPM.Y's revenue (0.6% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: ALPM.Y's revenue (0.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ALPM.Y's Return on Equity is forecast to be low in 3 years time (11.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y